Fineline Cube

Follow:
14463 Articles
Policy / Regulatory

China’s CDE Issues Draft Guidelines for Overseas Drug Market Approval Filings

CompanyDeals

BMS to Acquire Karuna Therapeutics for $14 Billion, Expanding Psychosis Treatment Portfolio

Company

CStone Pharmaceuticals Disbands Sales Team for Gavreto After NRDL Setback

CompanyDeals

Roche Diagnostics and Beijing Strong Biotechnologies Deepen Ties to Innovate in Hemostasis Diagnostics

CompanyDrug

Asieris Pharmaceuticals Gets Australian Greenlight for Acinetobacter Infection Drug Trial

CompanyDeals

Kossel Medtech Secures Over $14 Million in Series B Financing to Boost International Expansion

CompanyDrug

Sino Biopharmaceutical Completes Enrollment for Phase III Trial of Anlotinib in Soft Tissue Sarcoma

CompanyDrug

Jiangsu Nhwa Pharmaceutical Gets NMPA Green Light for Schizophrenia Drug Trial

CompanyDrug

Legend Biotech’s Carvykti Therapy to Include Myeloid Neoplasms Warning in Label Update

CompanyDrug

Takeda’s Livtencity Receives NMPA Approval, a First in China for CMV Infection Treatment

CompanyDeals

China Grand Pharmaceutical to Acquire Majority Stake in Mitsubishi Tanabe’s Tianjin Subsidiary

CompanyMedical Device

Beijing Balance Medical Secures NMPA Approval for Innovative Mitral Valve Annuloplasty Ring